Skip to content
Screener

Precigen PGEN Gross margin

Discontinued — last reported Q2 '18

Gross margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
70.2%-0.1pp
Gilead Sciences logo
Gilead SciencesGILD
79.6%+1.1pp
Regenxbio logo
RegenxbioRGNX
59.7%+1.0pp
Opko Health logo
Opko HealthOPK
40.8%+8.1pp
ALN
Alnylam PharmaceuticalsALNY
79.8%-4.1pp
Amgen logo
AmgenAMGN
69.5%+5.0pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×—

Profitability

See full
Operating margin-2,890.9%—
Net margin-3,656%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

gross profit/total revenue=83.6%

Based on trailing twelve months.

The source filing: Precigen’s 10-Q, filed August 13, 2018. Open the filing →

Filed
Aug 13, 2018
Fiscal quarter
Q2 FY2018
Calendar quarter
Q2 2018
Accession
0001356090-18-000012

FAQ

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.